117 related articles for article (PubMed ID: 1315533)
1. Fucoidan is a non-anticoagulant inhibitor of intimal hyperplasia.
McCaffrey TA; Falcone DJ; Borth W; Brayton CF; Weksler BB
Biochem Biophys Res Commun; 1992 Apr; 184(2):773-81. PubMed ID: 1315533
[TBL] [Abstract][Full Text] [Related]
2. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan.
McCaffrey TA; Falcone DJ; Vicente D; Du B; Consigli S; Borth W
J Cell Physiol; 1994 Apr; 159(1):51-9. PubMed ID: 7511146
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin.
Orlandi A; Ropraz P; Gabbiani G
Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646
[TBL] [Abstract][Full Text] [Related]
4. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.
Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW
Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells.
McCaffrey TA; Falcone DJ
Mol Biol Cell; 1993 Mar; 4(3):315-22. PubMed ID: 8387357
[TBL] [Abstract][Full Text] [Related]
6. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.
Hlawaty H; Suffee N; Sutton A; Oudar O; Haddad O; Ollivier V; Laguillier-Morizot C; Gattegno L; Letourneur D; Charnaux N
Biochem Pharmacol; 2011 Jan; 81(2):233-43. PubMed ID: 20887714
[TBL] [Abstract][Full Text] [Related]
8. Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism.
Vischer P; Buddecke E
Eur J Cell Biol; 1991 Dec; 56(2):407-14. PubMed ID: 1802722
[TBL] [Abstract][Full Text] [Related]
9. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells.
Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD
Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.
Giraux JL; Matou S; Bros A; Tapon-Bretaudière J; Letourneur D; Fischer AM
Eur J Cell Biol; 1998 Dec; 77(4):352-9. PubMed ID: 9930660
[TBL] [Abstract][Full Text] [Related]
11. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
Reilly CF
J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
[TBL] [Abstract][Full Text] [Related]
12. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
13. Heparin inhibits SMC growth in the presence of human and fetal bovine serum.
Cindhuchao N; Quinn DA; Garg HG; Hales CA
Biochem Biophys Res Commun; 2003 Feb; 302(1):84-8. PubMed ID: 12593851
[TBL] [Abstract][Full Text] [Related]
14. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL
Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434
[TBL] [Abstract][Full Text] [Related]
15. A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation.
DiRenzo DM; Chaudhary MA; Shi X; Franco SR; Zent J; Wang K; Guo LW; Kent KC
Cell Signal; 2016 May; 28(5):498-505. PubMed ID: 26912210
[TBL] [Abstract][Full Text] [Related]
16. Heparin inhibition of human vascular smooth muscle cell hyperplasia.
Chan P; Mill S; Mulloy B; Kakkar V; Demoliou-Mason C
Int Angiol; 1992; 11(4):261-7. PubMed ID: 1338338
[TBL] [Abstract][Full Text] [Related]
17. Role of Galphaq in smooth muscle cell proliferation.
Tanski WJ; Roztocil E; Hemady EA; Williams JA; Davies MG
J Vasc Surg; 2004 Mar; 39(3):639-44. PubMed ID: 14981460
[TBL] [Abstract][Full Text] [Related]
18. Heparin and cilazapril together inhibit injury-induced intimal hyperplasia.
Clowes AW; Clowes MM; Vergel SC; Müller RK; Powell JS; Hefti F; Baumgartner HR
Hypertension; 1991 Oct; 18(4 Suppl):II65-9. PubMed ID: 1833326
[TBL] [Abstract][Full Text] [Related]
19. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
[TBL] [Abstract][Full Text] [Related]
20. Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1.
Selzman CH; Gaynor JS; Turner AS; Whitehill TA; Horwitz LD; Harken AH
J Surg Res; 1998 Dec; 80(2):380-5. PubMed ID: 9878341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
